Quantcast
Connect with us

‘Deplorable’: Trump condemned as America buys up nearly entire supply of COVID-19 drug

Published

on

President Donald Trump (Coast Guard photo by Petty Officer 1st Class Patrick Kelley.)

“It’s a very concerning precedent because if we see the vaccine coming from a U.S. company, we’re likely to see the same type of behavior and hoarding by the U.S. and other developed countries.”

Most of the world will not be able to make use of a modestly effective Covid-19 treatment for at least the next three months because the Trump administration this week bought up nearly the entire supply of the drug, a move critics said exposes the potentially deadly consequences of the U.S. president’s so-called “America First” approach in the context of a pandemic that has swept the globe.

ADVERTISEMENT

The Trump administration’s decision to purchase almost all of California-based Gilead Sciences’ projected stock of remdesivir through September was also viewed by observers as a glaring example of the “dysfunctional character” of a patent system that gives pharmaceutical giants decades of monopoly control over a drug that could save lives in the near-term.

“We knew Trump was Mr. ‘America first,’ but this is still a deplorable act in the face of a global crisis.”
—Michael Smith, University of Aberdeen

“This is what happens when the world relies on a broken system driven by greed and profit during a pandemic,” tweeted U.K.-based advocacy group Global Justice Now, which is urging governments to override Gilead’s patent through compulsory licensing.

“Governments have a right to override this ludicrous patent system under international law, and they should take the opportunity to do that now, saving the [National Health Service] and patients around the world from the profiteering of these dysfunctional corporations,” Nick Dearden, director of Global Justice Now, said in a statement.

On Monday—the same day Gilead unveiled its pricing plan for remdesivir—the U.S. Health and Human Services Department (HHS) announced it “has secured more than 500,000 treatment courses of the drug for American hospitals through September.” The company said it will charge U.S. hospitals around $3,120 per privately insured patient for a treatment course of remdesivir, a price consumer advocacy group Public Citizen condemned as “offensive” given that U.S. taxpayers poured more than $70 million into developing the drug.

ADVERTISEMENT

HHS said its purchase “represents 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production in August (174,900 treatment courses), and 90 percent of production in September (232,800 treatment courses), in addition to an allocation for clinical trials.”

HHS Secretary Alex Azar gushed in a statement that President Donald Trump “has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for Covid-19” as infections continue to surge in dozens of states across the U.S.

But as The Guardian reported Tuesday, “experts and campaigners are alarmed both by the U.S. unilateral action on remdesivir and the wider implications, for instance in the event of a vaccine becoming available. The Trump administration has already shown that it is prepared to outbid and outmaneuver all other countries to secure the medical supplies it needs for the U.S.”

ADVERTISEMENT

ADVERTISEMENT

Michael Smith, head of politics and international relations at the University of Aberdeen in Scotland, tweeted Wednesday that “we knew Trump was Mr. ‘America first,’ but this is still a deplorable act in the face of a global crisis.”

“With a pandemic like Covid-19, the problem won’t be solved until it’s sold for the whole world.”
—Dr. Deborah Gleeson, La Trobe University

The Guardian noted that the U.K. and other nations still have the option of purchasing the drug through “generic companies in Bangladesh or India, where Gilead’s patent is not recognized.”

ADVERTISEMENT

Gilead ignored calls from civil society organizations around the world to relinquish its exclusive control over remdesivir and take steps to ensure that the treatment is widely available to those in need regardless of where they live or their ability to pay.

“An exclusivity and monopoly-based approach will fail the world in combating the Covid-19 pandemic,” more than 150 organizations and experts warned in an open letter in March. “Gilead must act in the public interest now.”

Dr. Deborah Gleeson, a senior public health lecturer at La Trobe University in Australia, told a local news outlet Wednesday that “it’s quite outrageous that the U.S. government has bought up almost the entire next three months supply of remdesivir.”

“It’s a very concerning precedent because if we see the vaccine coming from a U.S. company, we’re likely to see the same type of behavior and hoarding by the U.S. and other developed countries,” said Gleeson. “With a pandemic like Covid-19, the problem won’t be solved until it’s sold for the whole world.”

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

2020 Election

Trump can ‘rage from the balcony’ but he ‘will not succeed’: Dem super lawyer promises to protect the vote

Published

on

President Donald Trump has a lot of options available to him when it comes to his attempt to steal the election. That doesn't mean they'll work, however.

In an interview with Democratic "super-lawyer" Bob Bauer, "The Circus's" John Heilemann listed a few scenarios for Trump trying to steal the election.

"We already have an electoral infrastructure -- a voting system -- that is not always adequately resourced or supported," Bauer explained. "You take that system, you layer on top of it a pandemic, you lay on top of that destructive behavior by one of the major political parties who espouses this kind of nonsense, and you add on top of that the internet-distributed misinformation plays, and that just means that the task that you have to address these contingencies is much larger than it's been as a structural matter any time in the past."

Continue Reading

2020 Election

Will American elections ever again be legitimate?

Published

on

Only an established, legal “right to vote“ can defeat Republican voter suppression.

Republican politicians and conservative commentators are shocked, shocked! that Chief Justice John Roberts would say that people who voted before election day in Pennsylvania but their ballots were delayed by Lewis DeJoy’s sabotage of the Post Office should have their vote counted.

Increasingly, this election is coming down to the simple question of how effective 40 years of concerted Republican voter suppression efforts will be.

Their main strategy, particularly since George and Jeb Bush got together in 2000 to use a Texas felon list to purge 90,000 Black people off voting roles in Florida, has been removing the names of people who are legitimate voters.

Continue Reading
 

2020 Election

Melania Trump cancels appearance at Pennsylvania rally due to ‘lingering cough’

Published

on

First Lady Melania Trump has cancelled an appearance at a Pennsylvania rally with President Donald Trump due to her ongoing COVID-19 symptoms.

The first lady was slated to travel with the president on Tuesday to her first rally since receiving the COVID-19 diagnosis.

"Mrs. Trump continues to feel better every day following her recovery from COVID-19, but with a lingering cough, and out of an abundance of caution, she will not be traveling today," a statement from the First Lady's Office said.

CONFIRMED: Melania Trump will no longer accompany her husband to PA tonight, per her spokeswoman: "Mrs. Trump continues to feel better every day following her recovery from COVID-19, but with a lingering cough, and out of an abundance of caution, she will not be traveling today."

Continue Reading
 
 
Democracy is in peril. Invest in progressive news. Join Raw Story Investigates for $1. Go ad-free. LEARN MORE